Abstract:Trichosanthin (TCS), extracted from the Chinese medicinal herb Trichosanthes kirilowi , has shown promise for the inhibition of tumor growth. However, its immunomodulatory effect on tumor–host interaction remains unknown. In this study, we focused on the effect of TCS on murine anti-tumor immune response in the 3LL Lewis lung carcinoma tumor model and explored the possible molecular pathways involved. In addition to inhibiting cell proliferation and inducing apoptosis in the 3LL tumor, TCS retarded tumor growth and prolonged mouse survival more significantly in C57BL/6 immunocompetent mice than in nude mice. This reflected the fact that the host immune system was involved in tumor eradication. Using FACS analysis, we found that TCS increased the percentage of effector T cells, particularly Interferon-gamma (IFN-γ) producing CD4 + and CD8 + T cells from tumor-bearing mice. TCS also promoted the vigorous proliferation of antigen-specific effector T cells, markedly increased Th1 cytokine secretion and elicited more memory T cells in tumor-bearing mice, consequently enhancing the anti-tumor response and inducing immune protection. Furthermore, we found that TCS upregulated the expression of tumor suppressor in lung cancer 1 (TSLC1) in 3LL tumor cells and the expression of its ligand, class I-restricted T cell-associated molecule (CRTAM), in effector T cells. Blocking TSLC1 expression with small interfering RNA (siRNA) significantly eliminated the effects of TCS on the proliferation and cytokine secretion of effector T cells, suggesting that TCS enhances anti-tumor immune response at least partially by boosting the interaction between TSLC1 and CRTAM. Collectively, our data demonstrate that TCS not only affects tumor cells directly, but also enhances anti-tumor immunity via the interaction between TSLC1 and CRTAM. These findings may lead to the development of a novel approach for tumor regression.

Study on the bioactivity and immunogenicity of TCSKR173-174CG,a trichosanthin mutant

Site-Directed Mutagenesis and Prokaryotic Expression of Trichosanthin

Capillary Electrophoresis and Circular Dichroism Study of Trichosanthin and Its Mutants

Site-directed Mutation of Trichosanthin and Chemical Modification of Mutant by Polyethylene Glycol

Expression and Purification of Mutant Trichosanthin in Escherichia Coli

HIGH-LEVEL EXPRESSION OF RECOMBINANT TRICHOSANTHIN IN ESCHERICHIA COLI AND EVALUATION OF ITS IMMUNOGENICITY

High--level Expression of Recombinant Trichosanthin in {\sl Escherichia Coli} and Evaluation of Its Immunogenicity

The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability.

Y55 and D78 Are Crucial Amino Acid Residues of a New IgE Epitope on Trichosanthin

Tetrastigma Hemsleyanum Tubers Polysaccharide Ameliorates LPS-induced Inflammation in Macrophages and Caenorhabditis Elegans.

Identification Of The Amino Acid Residues In Trichosanthin Crucial For Ige Response

Anti-Hiv Agent Trichosanthin Enhances the Capabilities of Chemokines to Stimulate Chemotaxis and G Protein Activation, and This is Mediated Through Interaction of Trichosanthin and Chemokine Receptors

Effect of Site-Directed PEGylation of Trichosanthin on Its Biological Activity, Immunogenicity, and Pharmacokinetics

Crystallization and Preliminary X-Ray Crystallographic Studies of Trichosanthin Delta C7.

Cloning and DNA sequencing of the gene encoding trichosanthin]

Substrate Binding and Catalysis in Trichosanthin Occur in Different Sites As Revealed by the Complex Structures of Several E85 Mutants.

The Anti-Viral Protein of Trichosanthin Penetrates into Human Immunodeficiency Virus Type 1.

Possible mechanisms of trichosanthin-induced apoptosis of tumor cells.

Tandem Fusion of Albumin-Binding Domains Promoted Soluble Expression and Stability of Recombinant Trichosanthin in Vitro and in Vivo.

Stemucronatoside K, a Novel C21 Steroidal Glycoside from Stephanotis Mucronata, Inhibited the Cellular and Humoral Immune Response in Mice

Trichosanthin Enhances Anti-Tumor Immune Response in a Murine Lewis Lung Cancer Model by Boosting the Interaction Between TSLC1 and CRTAM